Longmont is AGC Biologics' North American Hub for cell and gene therapy services. The site's capabilities include viral vector development, characterization, and manufacturing in adherent and suspension environments, along with cell culture and modification development and manufacturing using the latest industry technologies and methodologies.
Our scientists here have an established track record of 20+ years of experience working with complex cell therapy and viral vector products and substances.
Tony Fraij
